First Potential Drug for NASH Granted Fast Track Designation

Article

Shire's investigational SHP626 (volixibat) treatment for nonalcoholic steatohepatitis with liver fibrosis has just received fast track designation from the FDA.

Shire’s investigational SHP626 (volixibat) treatment for nonalcoholic steatohepatitis (NASH) with liver fibrosis has just received fast track designation from the FDA.

The treatment is being developed as a once-daily, orally-administered inhibitor of the apical sodium dependent bile acid transporter, a protein primarily responsible for recycling bile acids from the intestine to the liver. Importantly, there are no currently approved drugs for NASH, a serious, chronic liver disease.

“Shire’s development plan for SHP626 is designed to address the unmet need in the treatment of adult patients who have NASH with liver fibrosis,” said Philip J. Vickers, PhD, head of R&D at Shire. “This fast track designation is further recognition of the critical need to develop new, effective therapeutic options for patients with this serious condition.”

The designation for NASH was supported by preclinical and phase 1 studies that assessed the safety and tolerability of the drug compared with placebo in healthy volunteers, as well as in overweight and obese patients. Shire is also set to start a phrase 2 trial, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and efficacy of 3 doses of SHP626 given to adult patients over the course of 48 weeks.

Adverse events that occurred in phase 1 trials were predominantly diarrhea that wasn’t considered serious. One serious adverse event that led to treatment discontinuation was alanine aminotransferase elevation.

Related Videos
Image credit: Azee/peopleimages.com | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store- Image credit: C Daniels/peopleimages.com | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.